ArticleThe British journal of dermatology2025

Rigosertib as a potential therapeutic option for patients with recessive dystrophic epidermolysis bullosa squamous cell carcinoma.

John J G Pritchard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.